In this study, we examined the mechanisms underlying the abnormal expression of CTSB during AD progression and explored how the miR‐96‐5p/CTSB signaling pathway contributes to cognition impairment, as well as its potential as a target for early diagnosis and therapeutic intervention in AD. The gene discussed is CTSB; the disease is Alzheimer disease.